drugset / Trial / NCT03402165

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

NCT03402165

Phase 4 Unknown 1200 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

Alpha-fetoprotein Levels on the Response to direct Antiviral Therapy in Patients with Chronic Hepatitis C

Timeline

Start
2017-01-01
Primary completion
2022-12-01
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Daklatasuvir Unknown
Subject Ledipasvir Small molecule
Subject Sofosbuvir Small molecule